Decision-making in acute viral bronchiolitis: A universal guideline and a publication gap

Jochen Meyburg1, Markus Ries2

  • 1Department of General Pediatrics and Pediatric Intensive Care, Center of Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Plos One
|August 19, 2020
PubMed

Insights

A significant publication gap exists for acute viral bronchiolitis treatments, with many studies remaining unpublished. This gap may have influenced the American Academy of Pediatrics (AAP) guideline recommendations for pediatric respiratory illness.

Area of Science:

  • Pediatrics
  • Clinical Research
  • Evidence-Based Medicine

Background:

  • Acute viral bronchiolitis is a common pediatric respiratory illness requiring hospitalization for severe cases.
  • The 2014 American Academy of Pediatrics (AAP) guideline for bronchiolitis is widely adopted globally.
  • A potential publication bias in clinical medicine may affect such guidelines.

Purpose of the Study:

  • To investigate the publication gap for clinical trials on acute viral bronchiolitis treatment.
  • To assess the impact of the AAP guideline on study publication rates.

Main Methods:

  • Analyzed studies registered on ClinicalTrials.gov marked as completed by October 2018.
  • Searched major trial and literature databases for publications.
  • Contacted study investigators directly to identify unpublished trials.

Main Results:

  • Only 72% of 69 registered acute viral bronchiolitis trials were published by November 2019.
  • Unpublished trials included data from 4,687 patients.
  • Publication rates dropped from 80% before 2014 to 40% after the AAP guideline release.

Conclusions:

  • A substantial publication bias affects acute viral bronchiolitis research.
  • This bias may have influenced the AAP guideline's recommendations.
  • The guideline itself might have inadvertently discouraged publication of post-release study findings.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
638
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
340
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.9K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.1K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K